Clinical Trial Update: MDMA Plus Exposure Therapy for PTSD [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MDMA-assisted exposure therapy for post-traumatic stress disorder is currently enrolling by invitation at Emory University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Emory University | Conditions: PTSD | Phase 2 | Status: ENROLLING_BY_INVITATION